· Venture Capital Tracker · investment-strategies · 1 min read
Blisce Follows On in Talkiatry Series D for Virtual Psychiatry
Blisce, the B Corp transatlantic firm founded by Alexandre Mars, made a follow-on investment in Talkiatry’s Series D for virtual psychiatry.
Blisce made a follow-on investment in Talkiatry’s Series D in February 2026, backing the virtual psychiatry provider — its most recent tracked deal.
Key facts
- Investor: Blisce (follow-on)
- Company: Talkiatry (virtual psychiatry)
- Round: Series D
- Date: February 2026
- Firm: Transatlantic B Corp founded by Alexandre Mars; donates 20% of carry to Epic Foundation
Why this matters
Talkiatry reflects Blisce’s mission-driven growth thesis across consumer and health. The firm’s prior winners include Spotify, Pinterest, Headspace, and Too Good To Go.
Sources
- Blisce recent investments (Tracxn): https://tracxn.com/d/venture-capital/blisce/__ZN5jMnsWy_qYXFvlc-H2_5P3898cpIBSBE6d58I0xKM
- Blisce firm profile (Groupe SEB): https://www.groupeseb.com/en/news/groupe-seb-invests-blisce-first-certified-b-corporation-transatlantic-vc-fund
- blisce
- series-d
- healthcare
- +2 more
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
